Emgesan

Emgesan tablets contain magnesium and are used to prevent and treat magnesium deficiency in adults.

Form
tabletti
Strength
250 mg
Active Ingredient
Magnesium hydroxide
Manufacturer
Viatris Oy

How to Use

Dosage

The usual dose for adults is ½ to 2 tablets daily.

Method

You can take Emgesan with or without food.

Important

Maximum 2 tablets per day.

Possible Side Effects

COMMON
  • Diarrhea
  • Stomach and gut irritation
RARE
  • Too much magnesium in the blood (hypermagnesemia), seen after long-term use in patients with kidney problems.
  • Stomach pain

Important Warnings

  • Do not use Emgesan if you are allergic to magnesium hydroxide or any other ingredient in this medicine.
  • Do not use Emgesan if you have severe kidney disease, a chronic urinary tract infection, or inflammatory kidney stones.
  • Talk to your doctor or pharmacist before use if you have kidney problems, a chronic urinary tract infection, or kidney stones.
  • Talk to your doctor or pharmacist if you have an endocrine disorder, such as too much aldosterone, overactive parathyroid glands with high calcium, or an overactive thyroid gland, or if your parathyroid gland has been removed.
  • Talk to your doctor or pharmacist if you have Bartter's syndrome.
Show 4 more warnings
  • Talk to your doctor or pharmacist if you have abnormally low magnesium levels in your blood.
  • Emgesan is not recommended for children and adolescents under 18 years old, especially if they have kidney problems or are dehydrated, as it can cause very high magnesium levels.
  • Avoid taking other antacid medicines that contain magnesium.
  • Tell your doctor or pharmacist about all other medicines you are taking, especially if they can harm your kidneys, are diuretics, or are medicines whose absorption Emgesan can reduce (like certain antibiotics, heart medicines, or thyroid hormones). Take Emgesan at least two hours apart from these medicines.

Use in Elderly Patients

Category C

Suitable for older adults, with specific precautions. Avoid use in severe renal impairment. Take the several interactions in the absorption phase into account. (updated 25.11.2024)